ArkAb is created

We are happy to let you know that we created yesterday the company ArkAb, B Cell Design subsidiary! ArkAb remain focused on developing chimeric antibodies for in vitro diagnostics and research markets. B Cell Design keeps its activity of developing innovative therapeutic candidates.

Go back